These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9100989)

  • 41. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
    Hoggard PG; Kewn S; Barry MG; Khoo SH; Back DJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1231-6. PubMed ID: 9174176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine.
    Cammack N; Rouse P; Marr CL; Reid PJ; Boehme RE; Coates JA; Penn CR; Cameron JM
    Biochem Pharmacol; 1992 May; 43(10):2059-64. PubMed ID: 1318048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conjugates of phosphorylated zalcitabine and lamivudine with SiO
    Vasilyeva SV; Shtil AA; Petrova AS; Balakhnin SM; Achigecheva PY; Stetsenko DA; Silnikov VN
    Bioorg Med Chem; 2017 Mar; 25(5):1696-1702. PubMed ID: 28169081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2', 3'-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells.
    Han T; Fernandez M; Sarkar M; Agarwal RP
    Life Sci; 2004 Jan; 74(7):835-42. PubMed ID: 14659972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
    Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
    Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
    Magnani M; Brandi G; Casabianca A; Fraternale A; Schiavano GF; Rossi L; Chiarantini L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.
    Stein DS; Moore KH
    Pharmacotherapy; 2001 Jan; 21(1):11-34. PubMed ID: 11191730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NDP kinase reactivity towards 3TC nucleotides.
    Kreimeyer A; Schneider B; Sarfati R; Faraj A; Sommadossi JP; Veron M; Deville-Bonne D
    Antiviral Res; 2001 May; 50(2):147-56. PubMed ID: 11369435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation.
    Veal GJ; Hoggard PG; Barry MG; Khoo S; Back DJ
    AIDS; 1996 May; 10(5):546-8. PubMed ID: 8724049
    [No Abstract]   [Full Text] [Related]  

  • 50. Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells.
    Yusa K; Oh-hara T; Yamazaki A; Tsukahara S; Satoh W; Tsuruo T
    Biochem Biophys Res Commun; 1990 Jun; 169(3):986-90. PubMed ID: 2163639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ddC and AZT on locomotion and acoustic startle. I: Acute effects in female rats.
    Morse DE; Davis HD; Popke EJ; Brown KJ; O'Donoghue VA; Grunberg NE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):221-8. PubMed ID: 9050078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A re-evaluation of zalcitabine.
    Moyle G
    Expert Opin Investig Drugs; 1998 Mar; 7(3):451-62. PubMed ID: 15991985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase.
    Ullman B
    Adv Exp Med Biol; 1989; 253B():415-20. PubMed ID: 2558543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clarithromycin does not affect phosphorylation of zidovudine in vitro.
    Rana KZ; Darnowski JW; Strayer AH; Dudley MN
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1945-7. PubMed ID: 8843311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyurea.
    Palmer S; Cox S
    Antimicrob Agents Chemother; 1997 Feb; 41(2):460-4. PubMed ID: 9021208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short communication cellular pharmacology of 9-(beta-D-1,3-dioxolan-4-yl) guanine and its lack of drug interactions with zidovudine in primary human lymphocytes.
    Hernandez-Santiago BI; Obikhod A; Fromentin E; Hurwitz SJ; Schinazi RF
    Antivir Chem Chemother; 2007; 18(6):343-6. PubMed ID: 18320938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular phosphorylation of zidovudine in an in vitro hollow fiber model.
    Rana KZ; Dudley MN
    Pharmacotherapy; 1999 Aug; 19(8):979-83. PubMed ID: 10453969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.
    Holdich T; Shiveley LA; Sawyer J
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2943-7. PubMed ID: 17242147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.
    Barry M; Mulcahy F; Merry C; Gibbons S; Back D
    Clin Pharmacokinet; 1999 Apr; 36(4):289-304. PubMed ID: 10320951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral therapy for patients with HIV disease.
    Barry M; Mulcahy F; Back DJ
    Br J Clin Pharmacol; 1998 Mar; 45(3):221-8. PubMed ID: 9517365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.